Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 92 entries
Sorted by: Best Match Show Resources per page
Survival benefit of postoperative radiation in papillary meningioma: Analysis of the National Cancer Data Base.

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology

Sumner WA, Amini A, Hankinson TC, Foreman NK, Gaspar LE, Kavanagh BD, Karam SD, Rusthoven CG, Liu AK.
PMID: 29123457
Rep Pract Oncol Radiother. 2017 Nov-Dec;22(6):495-501. doi: 10.1016/j.rpor.2017.10.001. Epub 2017 Oct 28.

AIM/BACKGROUND: Papillary meningioma represents a rare subset of World Health Organization (WHO) Grade III meningioma that portends an overall poor prognosis. There is relatively limited data regarding the benefit of postoperative radiation therapy (PORT). We used the National Cancer...

Cite
Sumner WA, Amini A, Hankinson TC, et al. Survival benefit of postoperative radiation in papillary meningioma: Analysis of the National Cancer Data Base. Rep Pract Oncol Radiother. 2017;22(6):495-501doi: 10.1016/j.rpor.2017.10.001.
Sumner, W. A., Amini, A., Hankinson, T. C., Foreman, N. K., Gaspar, L. E., Kavanagh, B. D., Karam, S. D., Rusthoven, C. G., & Liu, A. K. (2017). Survival benefit of postoperative radiation in papillary meningioma: Analysis of the National Cancer Data Base. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 22(6), 495-501. https://doi.org/10.1016/j.rpor.2017.10.001
Sumner, Whitney A, et al. "Survival benefit of postoperative radiation in papillary meningioma: Analysis of the National Cancer Data Base." Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology vol. 22,6 (2017): 495-501. doi: https://doi.org/10.1016/j.rpor.2017.10.001
Sumner WA, Amini A, Hankinson TC, Foreman NK, Gaspar LE, Kavanagh BD, Karam SD, Rusthoven CG, Liu AK. Survival benefit of postoperative radiation in papillary meningioma: Analysis of the National Cancer Data Base. Rep Pract Oncol Radiother. 2017 Nov-Dec;22(6):495-501. doi: 10.1016/j.rpor.2017.10.001. Epub 2017 Oct 28. PMID: 29123457; PMCID: PMC5671614.
Copy Download .nbib Format: NLM
Record maximum oscillation frequency in C-face epitaxial graphene transistors.

Nano letters

Guo Z, Dong R, Chakraborty PS, Lourenco N, Palmer J, Hu Y, Ruan M, Hankinson J, Kunc J, Cressler JD, Berger C, de Heer WA.
PMID: 23418924
Nano Lett. 2013 Mar 13;13(3):942-7. doi: 10.1021/nl303587r. Epub 2013 Feb 21.

The maximum oscillation frequency (fmax) quantifies the practical upper bound for useful circuit operation. We report here an fmax of 70 GHz in transistors using epitaxial graphene grown on the C-face of SiC. This is a significant improvement over...

Cite
Guo Z, Dong R, Chakraborty PS, et al. Record maximum oscillation frequency in C-face epitaxial graphene transistors. Nano Lett. 2013;13(3):942-7doi: 10.1021/nl303587r.
Guo, Z., Dong, R., Chakraborty, P. S., Lourenco, N., Palmer, J., Hu, Y., Ruan, M., Hankinson, J., Kunc, J., Cressler, J. D., Berger, C., & de Heer, W. A. (2013). Record maximum oscillation frequency in C-face epitaxial graphene transistors. Nano letters, 13(3), 942-7. https://doi.org/10.1021/nl303587r
Guo, Zelei, et al. "Record maximum oscillation frequency in C-face epitaxial graphene transistors." Nano letters vol. 13,3 (2013): 942-7. doi: https://doi.org/10.1021/nl303587r
Guo Z, Dong R, Chakraborty PS, Lourenco N, Palmer J, Hu Y, Ruan M, Hankinson J, Kunc J, Cressler JD, Berger C, de Heer WA. Record maximum oscillation frequency in C-face epitaxial graphene transistors. Nano Lett. 2013 Mar 13;13(3):942-7. doi: 10.1021/nl303587r. Epub 2013 Feb 21. PMID: 23418924.
Copy Download .nbib Format: NLM
Minocycline-induced hyperpigmentation.

Journal of community hospital internal medicine perspectives

Fiscus V, Hankinson A, Alweis R.
PMID: 25147636
J Community Hosp Intern Med Perspect. 2014 Jul 31;4. doi: 10.3402/jchimp.v4.24063. eCollection 2014.

A 62-year-old male with a long history of rosacea, which was well controlled on minocycline, presented to his primary care physician for routine examination. Physical examination was noted for non-palpable, non-pruritic blue patches of hyperpigmentation on the medial aspects...

Cite
Fiscus V, Hankinson A, Alweis R. Minocycline-induced hyperpigmentation. J Community Hosp Intern Med Perspect. 2014;4doi: 10.3402/jchimp.v4.24063.
Fiscus, V., Hankinson, A., & Alweis, R. (2014). Minocycline-induced hyperpigmentation. Journal of community hospital internal medicine perspectives, 4. https://doi.org/10.3402/jchimp.v4.24063
Fiscus, Valena, et al. "Minocycline-induced hyperpigmentation." Journal of community hospital internal medicine perspectives vol. 4 (2014). doi: https://doi.org/10.3402/jchimp.v4.24063
Fiscus V, Hankinson A, Alweis R. Minocycline-induced hyperpigmentation. J Community Hosp Intern Med Perspect. 2014 Jul 31;4. doi: 10.3402/jchimp.v4.24063. eCollection 2014. PMID: 25147636; PMCID: PMC4120055.
Copy Download .nbib Format: NLM
N-methyl-D-aspartate antagonists for stroke and head trauma.

Expert opinion on investigational drugs

Wood PL, Hawkinson JE.
PMID: 15989606
Expert Opin Investig Drugs. 1997 Apr;6(4):389-97. doi: 10.1517/13543784.6.4.389.

The N-methyl-D-aspartate (NMDA) receptor is a ligand-gated ion channel which is widely distributed in the central nervous system (CNS), and which mediates most of the fast excitatory neuronal transmission in the CNS. As with other ligand-gated ion channels, the...

Cite
Wood PL, Hawkinson JE. N-methyl-D-aspartate antagonists for stroke and head trauma. Expert Opin Investig Drugs. 1997;6(4):389-97doi: 10.1517/13543784.6.4.389.
Wood, P. L., & Hawkinson, J. E. (1997). N-methyl-D-aspartate antagonists for stroke and head trauma. Expert opinion on investigational drugs, 6(4), 389-97. https://doi.org/10.1517/13543784.6.4.389
Wood, P L, and Hawkinson, J E. "N-methyl-D-aspartate antagonists for stroke and head trauma." Expert opinion on investigational drugs vol. 6,4 (1997): 389-97. doi: https://doi.org/10.1517/13543784.6.4.389
Wood PL, Hawkinson JE. N-methyl-D-aspartate antagonists for stroke and head trauma. Expert Opin Investig Drugs. 1997 Apr;6(4):389-97. doi: 10.1517/13543784.6.4.389. PMID: 15989606.
Copy Download .nbib Format: NLM
The middle fossa transpetrous approach: experience with 13 cases.

Skull base surgery

Nassif PS, Hankinson HL, Horn KL.
PMID: 17171001
Skull Base Surg. 1997;7(1):5-14. doi: 10.1055/s-2008-1058618.

Surgical access to lesions of the temporal bone anterior to the internal auditory canal and medial to the petrous carotid artery has concerned surgeons for nearly a century. A variety of approaches have been developed to gain access to...

Cite
Nassif PS, Hankinson HL, Horn KL. The middle fossa transpetrous approach: experience with 13 cases. Skull Base Surg. 1997;7(1):5-14doi: 10.1055/s-2008-1058618.
Nassif, P. S., Hankinson, H. L., & Horn, K. L. (1997). The middle fossa transpetrous approach: experience with 13 cases. Skull base surgery, 7(1), 5-14. https://doi.org/10.1055/s-2008-1058618
Nassif, P S, et al. "The middle fossa transpetrous approach: experience with 13 cases." Skull base surgery vol. 7,1 (1997): 5-14. doi: https://doi.org/10.1055/s-2008-1058618
Nassif PS, Hankinson HL, Horn KL. The middle fossa transpetrous approach: experience with 13 cases. Skull Base Surg. 1997;7(1):5-14. doi: 10.1055/s-2008-1058618. PMID: 17171001; PMCID: PMC1656612.
Copy Download .nbib Format: NLM
Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk.

International journal of molecular epidemiology and genetics

Pinheiro SP, Gates MA, De Vivo I, Rosner BA, Tworoger SS, Titus-Ernstoff L, Hankinson SE, Cramer DW.
PMID: 21532843
Int J Mol Epidemiol Genet. 2010 Sep 03;1(4):320-31.

Inflammation and non-steroidal anti-inflammatory agents (NSAIDs) may play important role in ovarian cancer. However, epidemiologic data are inconsistent, possibly reflecting inter-individual genetic differences affecting the metabolism of NSAIDs. We examined whether common polymorphisms affecting the metabolism of NSAIDs modify...

Cite
Pinheiro SP, Gates MA, De Vivo I, et al. Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk. Int J Mol Epidemiol Genet. 2010;1(4):320-31
Pinheiro, S. P., Gates, M. A., De Vivo, I., Rosner, B. A., Tworoger, S. S., Titus-Ernstoff, L., Hankinson, S. E., & Cramer, D. W. (2010). Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk. International journal of molecular epidemiology and genetics, 1(4), 320-31.
Pinheiro, Simone P, et al. "Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk." International journal of molecular epidemiology and genetics vol. 1,4 (2010): 320-31.
Pinheiro SP, Gates MA, De Vivo I, Rosner BA, Tworoger SS, Titus-Ernstoff L, Hankinson SE, Cramer DW. Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk. Int J Mol Epidemiol Genet. 2010 Sep 03;1(4):320-31. PMID: 21532843; PMCID: PMC3076777.
Copy Download .nbib Format: NLM
Spirometry Longitudinal Data Analysis Software (SPIROLA) for Analysis of Spirometry Data in Workplace Prevention or COPD Treatment.

The open medical informatics journal

Hnizdo E, Yan T, Hakobyan A, Enright P, Beeckman-Wagner LA, Hankinson J, Fleming J, Lee Petsonk E.
PMID: 20835361
Open Med Inform J. 2010 Jul 08;4:94-102. doi: 10.2174/1874431101004010094.

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality. Periodic spirometry is often recommended for individuals with potential occupational exposure to respiratory hazards and in medical treatment of respiratory disease, to prevent COPD...

Cite
Hnizdo E, Yan T, Hakobyan A, et al. Spirometry Longitudinal Data Analysis Software (SPIROLA) for Analysis of Spirometry Data in Workplace Prevention or COPD Treatment. Open Med Inform J. 2010;4:94-102doi: 10.2174/1874431101004010094.
Hnizdo, E., Yan, T., Hakobyan, A., Enright, P., Beeckman-Wagner, L. A., Hankinson, J., Fleming, J., & Lee Petsonk, E. (2010). Spirometry Longitudinal Data Analysis Software (SPIROLA) for Analysis of Spirometry Data in Workplace Prevention or COPD Treatment. The open medical informatics journal, 494-102. https://doi.org/10.2174/1874431101004010094
Hnizdo, Eva, et al. "Spirometry Longitudinal Data Analysis Software (SPIROLA) for Analysis of Spirometry Data in Workplace Prevention or COPD Treatment." The open medical informatics journal vol. 4 (2010): 94-102. doi: https://doi.org/10.2174/1874431101004010094
Hnizdo E, Yan T, Hakobyan A, Enright P, Beeckman-Wagner LA, Hankinson J, Fleming J, Lee Petsonk E. Spirometry Longitudinal Data Analysis Software (SPIROLA) for Analysis of Spirometry Data in Workplace Prevention or COPD Treatment. Open Med Inform J. 2010 Jul 08;4:94-102. doi: 10.2174/1874431101004010094. PMID: 20835361; PMCID: PMC2936036.
Copy Download .nbib Format: NLM
Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome.

BMC clinical pathology

Shurubor YI, Matson WR, Willett WC, Hankinson SE, Kristal BS.
PMID: 17997839
BMC Clin Pathol. 2007 Nov 12;7:9. doi: 10.1186/1472-6890-7-9.

BACKGROUND: Biomarker-based assessments of biological samples are widespread in clinical, pre-clinical, and epidemiological investigations. We previously developed serum metabolomic profiles assessed by HPLC-separations coupled with coulometric array detection that can accurately identify ad libitum fed and caloric-restricted rats. These...

Cite
Shurubor YI, Matson WR, Willett WC, et al. Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome. BMC Clin Pathol. 2007;7:9doi: 10.1186/1472-6890-7-9.
Shurubor, Y. I., Matson, W. R., Willett, W. C., Hankinson, S. E., & Kristal, B. S. (2007). Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome. BMC clinical pathology, 79. https://doi.org/10.1186/1472-6890-7-9
Shurubor, Yevgeniya I, et al. "Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome." BMC clinical pathology vol. 7 (2007): 9. doi: https://doi.org/10.1186/1472-6890-7-9
Shurubor YI, Matson WR, Willett WC, Hankinson SE, Kristal BS. Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome. BMC Clin Pathol. 2007 Nov 12;7:9. doi: 10.1186/1472-6890-7-9. PMID: 17997839; PMCID: PMC2203971.
Copy Download .nbib Format: NLM
Early-Life Body Adiposity and the Breast Tumor Transcriptome.

Journal of the National Cancer Institute

Wang J, Peng C, Guranich C, Heng YJ, Baker GM, Rubadue CA, Glass K, Eliassen AH, Tamimi RM, Polyak K, Hankinson S.
PMID: 33136151
J Natl Cancer Inst. 2021 Jun 01;113(6):778-784. doi: 10.1093/jnci/djaa169.

BACKGROUND: Cumulative epidemiologic evidence has shown that early-life adiposity is strongly inversely associated with breast cancer risk throughout life, independent of adult obesity. However, the molecular mechanisms remain poorly understood.METHODS: We assessed the association of early-life adiposity, defined as...

Cite
Wang J, Peng C, Guranich C, et al. Early-Life Body Adiposity and the Breast Tumor Transcriptome. J Natl Cancer Inst. 2021;113(6):778-784doi: 10.1093/jnci/djaa169.
Wang, J., Peng, C., Guranich, C., Heng, Y. J., Baker, G. M., Rubadue, C. A., Glass, K., Eliassen, A. H., Tamimi, R. M., Polyak, K., & Hankinson, S. (2021). Early-Life Body Adiposity and the Breast Tumor Transcriptome. Journal of the National Cancer Institute, 113(6), 778-784. https://doi.org/10.1093/jnci/djaa169
Wang, Jun, et al. "Early-Life Body Adiposity and the Breast Tumor Transcriptome." Journal of the National Cancer Institute vol. 113,6 (2021): 778-784. doi: https://doi.org/10.1093/jnci/djaa169
Wang J, Peng C, Guranich C, Heng YJ, Baker GM, Rubadue CA, Glass K, Eliassen AH, Tamimi RM, Polyak K, Hankinson S. Early-Life Body Adiposity and the Breast Tumor Transcriptome. J Natl Cancer Inst. 2021 Jun 01;113(6):778-784. doi: 10.1093/jnci/djaa169. PMID: 33136151; PMCID: PMC8599920.
Copy Download .nbib Format: NLM
Malignant transformation in a cohort of patients with oral epithelial dysplasia.

The British journal of oral & maxillofacial surgery

Hankinson PM, Mohammed-Ali RI, Smith AT, Khurram SA.
PMID: 34303542
Br J Oral Maxillofac Surg. 2021 Nov;59(9):1099-1101. doi: 10.1016/j.bjoms.2021.02.019. Epub 2021 Mar 03.

Oral epithelial dysplasia (OED) is often diagnosed in oral potentially malignant disorders (OPMD) and carries an increased risk of malignant transformation. Currently, the reported risk of malignant transformation for OED varies. Here we present the risk in a cohort...

Cite
Hankinson PM, Mohammed-Ali RI, Smith AT, et al. Malignant transformation in a cohort of patients with oral epithelial dysplasia. Br J Oral Maxillofac Surg. 2021;59(9):1099-1101doi: 10.1016/j.bjoms.2021.02.019.
Hankinson, P. M., Mohammed-Ali, R. I., Smith, A. T., & Khurram, S. A. (2021). Malignant transformation in a cohort of patients with oral epithelial dysplasia. The British journal of oral & maxillofacial surgery, 59(9), 1099-1101. https://doi.org/10.1016/j.bjoms.2021.02.019
Hankinson, P M, et al. "Malignant transformation in a cohort of patients with oral epithelial dysplasia." The British journal of oral & maxillofacial surgery vol. 59,9 (2021): 1099-1101. doi: https://doi.org/10.1016/j.bjoms.2021.02.019
Hankinson PM, Mohammed-Ali RI, Smith AT, Khurram SA. Malignant transformation in a cohort of patients with oral epithelial dysplasia. Br J Oral Maxillofac Surg. 2021 Nov;59(9):1099-1101. doi: 10.1016/j.bjoms.2021.02.019. Epub 2021 Mar 03. PMID: 34303542.
Copy Download .nbib Format: NLM
Prolactin and Risk of Epithelial Ovarian Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Hathaway CA, Rice MS, Townsend MK, Hankinson SE, Arslan AA, Buring JE, Hallmans G, Idahl A, Kubzansky LD, Lee IM, Lundin EA, Sluss PM, Zeleniuch-Jacquotte A, Tworoger SS.
PMID: 34244157
Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1652-1659. doi: 10.1158/1055-9965.EPI-21-0139. Epub 2021 Jul 08.

BACKGROUND: Prolactin is synthesized in the ovaries and may play a role in ovarian cancer etiology. One prior prospective study observed a suggestive positive association between prolactin levels and risk of ovarian cancer.METHODS: We conducted a pooled case-control study...

Cite
Hathaway CA, Rice MS, Townsend MK, et al. Prolactin and Risk of Epithelial Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2021;30(9):1652-1659doi: 10.1158/1055-9965.EPI-21-0139.
Hathaway, C. A., Rice, M. S., Townsend, M. K., Hankinson, S. E., Arslan, A. A., Buring, J. E., Hallmans, G., Idahl, A., Kubzansky, L. D., Lee, I. M., Lundin, E. A., Sluss, P. M., Zeleniuch-Jacquotte, A., & Tworoger, S. S. (2021). Prolactin and Risk of Epithelial Ovarian Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(9), 1652-1659. https://doi.org/10.1158/1055-9965.EPI-21-0139
Hathaway, Cassandra A, et al. "Prolactin and Risk of Epithelial Ovarian Cancer." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,9 (2021): 1652-1659. doi: https://doi.org/10.1158/1055-9965.EPI-21-0139
Hathaway CA, Rice MS, Townsend MK, Hankinson SE, Arslan AA, Buring JE, Hallmans G, Idahl A, Kubzansky LD, Lee IM, Lundin EA, Sluss PM, Zeleniuch-Jacquotte A, Tworoger SS. Prolactin and Risk of Epithelial Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1652-1659. doi: 10.1158/1055-9965.EPI-21-0139. Epub 2021 Jul 08. PMID: 34244157; PMCID: PMC8419083.
Copy Download .nbib Format: NLM
Association of oral contraceptives and tubal ligation with antimüllerian hormone.

Menopause (New York, N.Y.)

Langton CR, Whitcomb BW, Purdue-Smithe AC, Sievert LL, Hankinson SE, Manson JE, Rosner BA, Bertone-Johnson ER.
PMID: 34873106
Menopause. 2021 Dec 06; doi: 10.1097/GME.0000000000001905. Epub 2021 Dec 06.

OBJECTIVE: Oral contraceptives (OCs) and tubal ligation are commonly used methods of contraception that may impact ovarian function. Few studies have examined the association of these factors with antimüllerian hormone (AMH), a marker of ovarian aging.METHODS: We examined the...

Cite
Langton CR, Whitcomb BW, Purdue-Smithe AC, et al. Association of oral contraceptives and tubal ligation with antimüllerian hormone. Menopause. 2021;doi: 10.1097/GME.0000000000001905.
Langton, C. R., Whitcomb, B. W., Purdue-Smithe, A. C., Sievert, L. L., Hankinson, S. E., Manson, J. E., Rosner, B. A., & Bertone-Johnson, E. R. (2021). Association of oral contraceptives and tubal ligation with antimüllerian hormone. Menopause (New York, N.Y.), . https://doi.org/10.1097/GME.0000000000001905
Langton, Christine R, et al. "Association of oral contraceptives and tubal ligation with antimüllerian hormone." Menopause (New York, N.Y.) vol. (2021). doi: https://doi.org/10.1097/GME.0000000000001905
Langton CR, Whitcomb BW, Purdue-Smithe AC, Sievert LL, Hankinson SE, Manson JE, Rosner BA, Bertone-Johnson ER. Association of oral contraceptives and tubal ligation with antimüllerian hormone. Menopause. 2021 Dec 06; doi: 10.1097/GME.0000000000001905. Epub 2021 Dec 06. PMID: 34873106.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 92 entries